Publication: Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
No Thumbnail Available
Identifiers
Date
2017
Authors
Argüelles-Arias, F
Guerra Veloz, M F
Perea Amarillo, R
Vilches-Arenas, A
Castro Laria, L
Maldonado Pérez, B
Chaaro, D
Benítez Roldán, A
Merino, V
Ramírez, G
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
